![]() |
JOURNAL TOOLS |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Estratti |
Permessi |

I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEWS
Italian Journal of Vascular and Endovascular Surgery 2008 March;15(1):17-27
Copyright © 2008 EDIZIONI MINERVA MEDICA
lingua: Inglese
Revascularization as the treatment of choice in atherosclerotic renal artery stenosis
Kolluri R. 1, 2, Partlow J. 2, Rocha-Singh K. 1, 2
1 Prairie Vascular Institute, Springfield, IL, USA 2 Prairie Education and Research Cooperative Springfield, IL, USA
The prevalence of renal artery stenosis (RAS) is more common than previously thought. It is the most common secondary cause of hypertension and is associated with progressive renal failure. RAS is an independent risk factor for cardiovascular mortality. Non invasive testing for RAS including renal artery duplex, magnetic resonance imaging, and computed tomography angiography are widely available. Percutaneous transluminal renal angioplasty and stenting (PTRAS) is the contemporary treatment of choice for atherosclerotic RAS and has been shown to improve the control of hypertension and preserve renal function in appropriately selected patients. Surveillance duplexes should be performed to assess in-stent restenosis. This article provides a contemporary review of the epidemiology, laboratory and imaging techniques, appropriate selection of patients with RAS who may benefit from PTRAS and associated complications.